Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia.

Jarskog LF, Dong Z, Kangarlu A, Colibazzi T, Girgis RR, Kegeles LS, Barch DM, Buchanan RW, Csernansky JG, Goff DC, Harms MP, Javitt DC, Keefe RS, McEvoy JP, McMahon RP, Marder SR, Peterson BS, Lieberman JA.

Neuropsychopharmacology. 2013 Jun;38(7):1245-52. doi: 10.1038/npp.2013.23. Epub 2013 Jan 16.

2.

Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study.

Sigmundsson T, Maier M, Toone BK, Williams SC, Simmons A, Greenwood K, Ron MA.

Schizophr Res. 2003 Nov 1;64(1):63-71.

PMID:
14511802
3.

Atypical antipsychotic drug treatment for 6 months restores N-acetylaspartate in left prefrontal cortex and left thalamus of first-episode patients with early onset schizophrenia: A magnetic resonance spectroscopy study.

Gan JL, Cheng ZX, Duan HF, Yang JM, Zhu XQ, Gao CY.

Psychiatry Res. 2014 Jul 30;223(1):23-7. doi: 10.1016/j.pscychresns.2014.04.010. Epub 2014 Apr 28.

PMID:
24831926
4.

Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.

Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.

J Psychiatr Res. 2007 Oct;41(8):625-34. Epub 2006 Sep 1.

PMID:
16949099
5.

Relationships between dorsolateral prefrontal cortex metabolic change and cognitive impairment in first-episode neuroleptic-naive schizophrenia patients.

Huang ML, Khoh TT, Lu SJ, Pan F, Chen JK, Hu JB, Hu SH, Xu WJ, Zhou WH, Wei N, Qi HL, Shang DS, Xu Y.

Medicine (Baltimore). 2017 Jun;96(25):e7228. doi: 10.1097/MD.0000000000007228.

6.

Adding Sarcosine to Antipsychotic Treatment in Patients with Stable Schizophrenia Changes the Concentrations of Neuronal and Glial Metabolites in the Left Dorsolateral Prefrontal Cortex.

Strzelecki D, Podgórski M, Kałużyńska O, Stefańczyk L, Kotlicka-Antczak M, Gmitrowicz A, Grzelak P.

Int J Mol Sci. 2015 Oct 15;16(10):24475-89. doi: 10.3390/ijms161024475.

7.

Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophrenia.

Coughlin JM, Tanaka T, Marsman A, Wang H, Bonekamp S, Kim PK, Higgs C, Varvaris M, Edden RA, Pomper M, Schretlen D, Barker PB, Sawa A.

Curr Mol Med. 2015;15(2):176-83.

8.

N-acetyl-aspartate levels in the dorsolateral prefrontal cortex in the early years of schizophrenia are inversely related to disease duration.

Molina V, Sánchez J, Reig S, Sanz J, Benito C, Santamarta C, Pascau J, Sarramea F, Gispert JD, Misiego JM, Palomo T, Desco M.

Schizophr Res. 2005 Mar 1;73(2-3):209-19. Review.

PMID:
15653263
9.

(1)H-magnetic resonance spectroscopy ((1)H-MRS) in methamphetamine dependence and methamphetamine induced psychosis.

Howells FM, Uhlmann A, Temmingh H, Sinclair H, Meintjes E, Wilson D, Stein DJ.

Schizophr Res. 2014 Mar;153(1-3):122-8. doi: 10.1016/j.schres.2014.01.029. Epub 2014 Feb 12.

PMID:
24529366
10.

Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia.

Javitt DC, Buchanan RW, Keefe RS, Kern R, McMahon RP, Green MF, Lieberman J, Goff DC, Csernansky JG, McEvoy JP, Jarskog F, Seidman LJ, Gold JM, Kimhy D, Nolan KS, Barch DS, Ball MP, Robinson J, Marder SR.

Schizophr Res. 2012 Apr;136(1-3):25-31. doi: 10.1016/j.schres.2011.11.001. Epub 2011 Dec 12.

PMID:
22169248
11.
12.
13.

Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis.

Kraguljac NV, Reid M, White D, Jones R, den Hollander J, Lowman D, Lahti AC.

Psychiatry Res. 2012 Aug-Sep;203(2-3):111-25. doi: 10.1016/j.pscychresns.2012.02.003. Epub 2012 Sep 13. Review.

14.

Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging.

Bertolino A, Kumra S, Callicott JH, Mattay VS, Lestz RM, Jacobsen L, Barnett IS, Duyn JH, Frank JA, Rapoport JL, Weinberger DR.

Am J Psychiatry. 1998 Oct;155(10):1376-83.

PMID:
9766769
15.

Antidepressant effect detected on proton magnetic resonance spectroscopy in drug-naïve female patients with first-episode major depression.

Kaymak SU, Demir B, Oğuz KK, Sentürk S, Uluğ B.

Psychiatry Clin Neurosci. 2009 Jun;63(3):350-6. doi: 10.1111/j.1440-1819.2009.01951.x.

16.

Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia.

Deicken RF, Zhou L, Schuff N, Weiner MW.

Schizophr Res. 1997 Oct 17;27(1):65-71.

PMID:
9373896
17.

1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients.

Brambilla P, Stanley JA, Nicoletti MA, Sassi RB, Mallinger AG, Frank E, Kupfer D, Keshavan MS, Soares JC.

J Affect Disord. 2005 May;86(1):61-7.

PMID:
15820271
18.

N-acetylaspartate reduction in the medial prefrontal cortex following 8 weeks of risperidone treatment in first-episode drug-naïve schizophrenia patients.

Zong X, Hu M, Li Z, Cao H, He Y, Liao Y, Zhou J, Sang D, Zhao H, Tang J, Lv L, Chen X.

Sci Rep. 2015 Mar 16;5:9109. doi: 10.1038/srep09109.

19.

Prefrontal grey and white matter neurometabolite changes after atomoxetine and methylphenidate in children with attention deficit/hyperactivity disorder: a (1)H magnetic resonance spectroscopy study.

Husarova V, Bittsansky M, Ondrejka I, Dobrota D.

Psychiatry Res. 2014 Apr 30;222(1-2):75-83. doi: 10.1016/j.pscychresns.2014.03.003. Epub 2014 Mar 15.

PMID:
24679996
20.

Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study.

Wood SJ, Berger GE, Lambert M, Conus P, Velakoulis D, Stuart GW, Desmond P, McGorry PD, Pantelis C.

Arch Gen Psychiatry. 2006 Sep;63(9):969-76.

PMID:
16952999

Supplemental Content

Support Center